RxDoctor Payments Data

Vincent Decicco, DO

Family Medicine · Pasadena, MDNPI 1841262953

Payments from drug & device makers

$845in general payments, 2019–2025

Across 43 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$231
  • Pfizer$121
  • Amgen$96
  • Novo Nordisk$78
  • Exact Sciences$46
  • Astellas Pharma US Inc$42
  • plus $232 from 11 others

What the payments were for

  • Food & beverage$845100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$845 in reported general payments places this provider in the 65th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$3,097
Medicare patients
16
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$28,660
PradaxaDabigatran Etexilate Mesylate82$23,049
XareltoRivaroxaban18$20,422
EliquisApixaban12$19,345
ArexvyRsvpref3 Antigen/As01e/Pf126$18,522
Spiriva RespimatTiotropium Bromide25$12,737
Wixela InhubFluticasone Propion/Salmeterol51$9,352
Atorvastatin Calcium452$5,170
Gabapentin122$3,595
Levothyroxine Sodium188$3,234
ShingrixVaricella-Zoster Ge/As01b/Pf16$3,200
Amlodipine Besylate248$2,880
Losartan Potassium197$2,223
Lisdexamfetamine Dimesylate11$2,048
Lisinopril182$2,012

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Pradaxa, Spiriva Respimat$13$64,446149 claims
GSKArexvy, Shingrix$21$21,722142 claims
PfizerEliquis$121$19,34512 claims
Lilly USA, LLCHumulin N$13$1,10115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Pasadena

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →